FindTrial
Sign In

Effect of combining dexmedetomidine and sufentanil for intravenous patient-controlled analgesia after laryngectomy

Effect of combining dexmedetomidine and sufentanil for intravenous patient-controlled analgesia after laryngectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-14004618
Enrollment
Unknown
Registered
2014-05-08
Start date
2014-05-23
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

laryngectomy

Interventions

DS:dexmedetomidine/sufentanil
S:sufentanil

Sponsors

Shanghai Eye, Ear, Nose, and Throat Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 69 Years

Inclusion criteria

Inclusion criteria: Aged between 40 and 69 years, ASA I or II, undergoing total or partial laryngectomy with general anaesthesia

Exclusion criteria

Exclusion criteria: Allergic to dexmedetomidine or sufentanil, Impaired hepatic and renal function, obesity, refusal to PCA

Design outcomes

Primary

MeasureTime frame
Cumulative PCA requirements, pain intensities, car;pain intensitie;—

Secondary

MeasureTime frame
cardiovascular and respiratory variable;—

Countries

China

Contacts

Public ContactShen Xia

Shanghai Eye, Ear, Nose, and Throat Hospital, Fudan University

zlsx@yahoo.com+86 021 64377134

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 10, 2026